Vanguard Group Inc Ovid Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,636,115 shares of OVID stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,636,115
Previous 3,108,781
15.2%
Holding current value
$1.45 Million
Previous $963,000
9.76%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding OVID
# of Institutions
71Shares Held
32.7MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$2.2 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.12 Million0.05% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$1.23 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$1.16 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.1MShares$1.15 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $38.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...